Skip to main content
Top
Published in: Journal of Gastroenterology 7/2018

01-07-2018 | Letter to the Editor

Prediabetes and subsequent pancreatic fat accumulation

Author: Tomoyuki Kawada

Published in: Journal of Gastroenterology | Issue 7/2018

Login to get access

Excerpt

Yamazaki et al. [1] investigated the effect of prediabetes on subsequent pancreatic fat accumulation, based on the hypothesis that pancreatic fat was a manifestation of disturbed glucose metabolism. Prediabetes was defined as fasting plasma glucose of 100–125 mg/dl or hemoglobin A1c of 5.7–6.4%, and the change of pancreatic fat was evaluated by computed tomography (CT). A total of 198 nondiabetic participants were composed of 48 prediabetes and 150 non-prediabetes participants. By multiple linear regression analysis, baseline prediabetes was associated with future pancreatic fat accumulation with beta value (95% confidence interval) of 3.14 (1.25–5.03). In addition, body mass index (BMI) and impaired fasting glucose (IFG) were also risk factors of pancreatic fat accumulation. I have some queries on their study. …
Literature
Metadata
Title
Prediabetes and subsequent pancreatic fat accumulation
Author
Tomoyuki Kawada
Publication date
01-07-2018
Publisher
Springer Japan
Published in
Journal of Gastroenterology / Issue 7/2018
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-018-1471-1

Other articles of this Issue 7/2018

Journal of Gastroenterology 7/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.